Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

Episode 44

0:00-1:04:18

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship. Sponsored by Leucentra, https://leucentra.com/ Inspired by science, empowered by IT. Leucentra helps life science and healthcare organizations evaluate, implement, and get more value from technology that supports innovation. Tracy Ryan, co-founder of NKore BioTherapeutics and former chief communications officer, joins Gregory Austin and Dr. Chad Briscoe to explain how her daughter Sophie’s pediatric brain tumor transformed her from a parent searching for options into a cancer advocate, research fundraiser, and biotechnology founder. The conversation examines the scientific reasoning that moved Tracy from medical cannabis advocacy toward NK-cell immunotherapy. She describes an immune-system finding involving Sophie’s natural killer cells, the work of the late UCLA scientist Dr. Anahid Jewett, and the development of an experimental allogeneic NK-cell platform designed to enhance immune activity without genetic engineering. The episode also explores the practical realities of translating an early scientific hypothesis into a therapeutic program, including donor selection, cell persistence, manufacturing, treatment outside the United States, regulatory requirements, clinical evidence, and the difficulty of raising capital for an emerging cell-therapy company.

Publisher

BioTalk Unzipped

Link

biotalk-unzipped.captivate.fm/episode/tracy-ryan-nk-cell-immunotherapy

Published

July 20, 2026

Duration

1h 4m

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Gregory Austin

BU

BioTalk Unzipped

@biotalkunzipped

#daughtersbraintumor #biotechfounder #tracyryan #lifesciences #medicine

The Nile